Balsara J J, Nandal N V, Burte N P, Jadhav J H, Chandorkar A G
Psychopharmacology (Berl). 1984;82(3):237-40. doi: 10.1007/BF00427781.
Pretreatment with the opiate antagonist naloxone, at 1.25-5 mg/kg, increased the intensity of methamphetamine stereotypy, had no effect (over a range of 0.3125-5 mg/kg) on apomorphine stereotypy, and antagonized haloperidol catalepsy in rats at 1.25-5 mg/kg. It is suggested that naloxone, by blocking the opiate receptors located on the nigro-striatal and mesolimbic dopamine (DA) nerve terminals, releases the DA systems from endogenous inhibition, presumably caused by endogenous opiate systems, and thereby potentiates methamphetamine stereotypy and antagonizes haloperidol catalepsy. However, the possibility that naloxone might have affected methamphetamine stereotypy and haloperidol catalepsy by modulating the activity of the central noradrenergic and GABAergic systems, which are reported to influence dopaminergically mediated behaviours, also needs to be considered.
以1.25 - 5毫克/千克的剂量用阿片类拮抗剂纳洛酮进行预处理,会增强甲基苯丙胺刻板行为的强度,在0.3125 - 5毫克/千克的剂量范围内对阿扑吗啡刻板行为没有影响,并且在1.25 - 5毫克/千克时能拮抗大鼠的氟哌啶醇僵住症。有人提出,纳洛酮通过阻断位于黑质 - 纹状体和中脑边缘多巴胺(DA)神经末梢上的阿片受体,使DA系统从可能由内源性阿片系统引起的内源性抑制中释放出来,从而增强甲基苯丙胺刻板行为并拮抗氟哌啶醇僵住症。然而,纳洛酮可能通过调节中枢去甲肾上腺素能和GABA能系统的活性来影响甲基苯丙胺刻板行为和氟哌啶醇僵住症的可能性也需要考虑,据报道这些系统会影响多巴胺介导的行为。